2,4-双三氟甲基氯苯, 98%

1-Chloro-2,4-bis(trifluoromethyl)benzene

[[2-（2-甲基哌啶-1-基）-2-氧代乙基]（苯基）-氨基]乙酸

[[2-(2-Methylpiperidin-1-yl)-2-oxoethyl](phenyl)-amino]acetic acid

4-(4-甲基苯氧基)苯甲腈,

Benzonitrile, 4-(4-Methylphenoxy)-

3-(3-吡啶基)-D-丙氨酸甲酯二盐酸盐

3-(3-Pyridyl)-D-alanine methyl ester dihydrochloride

试剂级

N- [4-（1-氨基乙基）苯基] -N'-苯基脲

N-[4-(1-aminoethyl)phenyl]-N′-phenylurea

N,N′-(1,2-二羟乙烯)二丙烯酰胺, >98.0%(T)

N,N′-(1,2-Dihydroxyethylene)bisacrylamide

N- [2-（5-氨基-1,3,4-噻二唑-2-基）乙基]苯甲酰胺

N-[2-(5-amino-1,3,4-thiadiazol-2-yl)ethyl]benzamide

乙基紫精二溴化物, 99%

Ethylviologen Dibromide

3-羟基苯甲酰肼

3-hydroxybenzoic hydrazide

99%

11β，17,21-三羟基-16α-甲基孕烯-1,4-二烯-3,20-二酮17,21-二丙酸酯

11β,17,21-Trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17,21-Dipropionate

4-甲基-3-氧代哌啶-1-羧酸叔丁酯, 98%

tert-Butyl 4-methyl-3-oxopiperidine-1-carboxylate

(7R,8S,9R,10S)-rel-7,8,9,10-四氢苯并[a]芘-7,8,9,10-四醇-d8

(7R,8S,9R,10S)-rel-7,8,9,10-Tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol-d8

对溴氯苯, 分析对照品,≥99.5%(GC)

1-Bromo-4-chlorobenzene

3-氯-4-[（4-甲氧基苯基）氨基] -1-（4-甲基苯基）-1H-吡咯-2,5-二酮

3-chloro-4-[(4-methoxyphenyl)amino]-1-(4-methylphenyl)-1H-pyrrole-2,5-dione

Secukinumab（抗IL-17A）

Secukinumab (anti-IL-17A)

99%

4-{[3-（4-氟苯基）-1,2,4-恶二唑-5-基]甲基}哌啶

4-{[3-(4-Fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine

3-(氯甲基)-吡唑并[1，5-a]嘧啶, 98%

3-(Chloromethyl)pyrazolo[1,5-a]pyrimidine

2-氨基-4-（4-乙基苯基）噻吩-3-羧酸异丙酯

Isopropyl 2-amino-4-(4-ethylphenyl)thiophene-3-carboxylate

(4S,5R)-5-(乙酰氧基甲基)四氢呋喃-2,4-二基 二乙酸酯, 98%

(4S,5R)-5-(Acetoxymethyl)tetrahydrofuran-2,4-diyl diacetate

1,3-双(1-金刚烷基)苯并咪唑氯化物

1,3-Bis(1-adamanthyl)benzimidazolium chloride

98%